Rayliant Quantitative Developed Market Equity ETF
RWLC - ETF AI Analysis
Top Page
Rayliant Quantitative Developed Market Equity ETF (RWLC)
RWLC, the Rayliant Quantitative Developed Market Equity ETF, has a solid overall rating, largely driven by its sizable positions in high-quality tech leaders like Apple, Microsoft, and Alphabet, which benefit from strong financial performance and long-term growth in areas such as cloud and AI. Nvidia and Gilead also support the fund’s quality through strong earnings and strategic growth initiatives, though some holdings like Altria and Amazon bring risks related to leverage, declining core markets, or premium valuations. The main risk factor is the fund’s meaningful concentration in large technology names, which can increase volatility if that sector faces a downturn.
RWLC vs. SPDR S&P 500 ETF (SPY)
- AUM
- 60.56M
- Region
- North America
- Expense Ratio
- 0.32%
- Beta
- 0.89
- Issuer
- Rayliant
- Inception Date
- Dec 16, 2021
- Dividend Yield
- 12.76%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
RWLC Summary
Rayliant Quantitative Developed Market Equity ETF (RWLC) is a U.S.-focused stock fund that uses a data-driven strategy instead of tracking a traditional index. It mainly invests in large, well-known companies and spreads money across many sectors, with a big tilt toward technology, finance, and health care. Top holdings include familiar names like Apple and Nvidia. Someone might invest in RWLC for broad diversification across leading U.S. companies and the potential for long-term growth. A key risk is that it is heavily exposed to the stock market, especially tech stocks, so its value can rise and fall sharply.
How much will it cost me?
This ETF has an expense ratio of 0.32%, which means you’ll pay about $3.20 per year for every $1,000 you invest. That’s higher than the average low-cost index ETF because it’s actively managed using quantitative strategies rather than simply tracking a market index.
What would affect this ETF?
This U.S.-focused ETF is heavily invested in large technology and health care companies like Apple, Nvidia, Microsoft, and Eli Lilly, so it could benefit from strong innovation, digital growth, and medical breakthroughs, as well as a stable U.S. economy. On the downside, it may be hurt by rising interest rates that pressure growth stocks, tighter regulations on big tech or health care, and any slowdown in consumer spending or financial markets that affects its broad mix of sectors.
RWLC Top 10 Holdings
This ETF leans heavily on U.S. Big Tech, with Apple and Microsoft doing much of the heavy lifting as their shares keep rising on strong earnings and cloud momentum. Nvidia and Micron add an AI and semiconductor twist, though Nvidia has been a bit mixed lately while Micron’s earlier surge is now cooling. Alphabet’s twin share classes have been lagging, acting like a small brake on the fund’s tech engine. Outside tech, Mastercard and Eli Lilly provide steadier support, but overall this is a U.S.-centric, technology-driven story.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Apple | 9.75% | $9.53M | $5.17T | 29.77% | 79Outperform | |
| Nvidia | 5.06% | $4.95M | $4.19T | -14.25% | 76Outperform | |
| Microsoft | 3.90% | $3.82M | $3.87T | 2.32% | 79Outperform | |
| Mastercard | 3.06% | $2.99M | $575.61B | 16.28% | 75Outperform | |
| Alphabet Class A | 2.90% | $2.84M | $3.57T | 4.18% | 85Outperform | |
| Eli Lilly & Co | 2.77% | $2.70M | $1.35T | 40.23% | 72Outperform | |
| Alphabet Class C | 2.48% | $2.42M | $3.57T | 2.76% | 82Outperform | |
| Amazon | 2.44% | $2.39M | $2.88T | 9.52% | 71Outperform | |
| Gilead Sciences | 2.39% | $2.34M | $210.52B | 36.10% | 78Outperform | |
| Altria Group | 2.13% | $2.08M | $128.73B | 34.23% | 64Neutral |
RWLC Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RWLC, the sentiment is Positive. The current price of 38.21 is below the 20-day moving average (MA) of 38.45, below the 50-day MA of 38.72, and above the 200-day MA of 36.42, indicating a neutral trend. The MACD of -0.28 indicates Positive momentum. The RSI at 47.04 is Neutral, neither overbought nor oversold. The STOCH value of 59.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RWLC.
RWLC Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $38.21 | $41.00(7.30% Upside) | $60.56M | 0.32% | 73Outperform | |
| $28.56 | $34.18(19.66% Upside) | $92.89M | 1.00% | 73Outperform | |
| $33.42 | $39.11(17.00% Upside) | $76.82M | 0.80% | 67Neutral | |
| $28.88 | $32.17(11.40% Upside) | $75.14M | 0.85% | 72Outperform | |
| $11.02 | $14.19(28.81% Upside) | $74.05M | 0.35% | 74Outperform | |
| $45.39 | $55.22(21.66% Upside) | $69.54M | 0.56% | 73Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| RWLC | Rayliant Quantitative Developed Market Equity ETF | 38.21 | 5.30 | 16.10% | |
| PRMR | PeakShares RMR Prime Equity ETF | 28.56 | 3.58 | 14.34% | |
| FCUS | Pinnacle Focused Opportunities ETF | 33.42 | 3.04 | 10.00% | |
| SPCT | Liberty One Spectrum ETF | 28.88 | 3.70 | 14.71% | |
| REGS | Columbia Large Cap Growth ETF | 11.02 | 0.93 | 9.21% | |
| LCF | Touchstone US Large Cap Focused ETF | 45.38 | 4.18 | 10.16% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
